1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

CML - 694

Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Preview of Adherence of Asciminib vs ATP-Competitive Tyrosine Kinase Inhibitors (TKIs) in Second Line (2L) for Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

View Poster Contact Presenter

Poster Presenter

Akriti G Jain

Authors

Akriti G Jain

Part of Topic

Chronic Myeloid Leukemia (CML)

Keywords: chronic myeloid leukemia, asciminib, tyrosine kinase inhibitor, adherence, early line treatment

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.